Company facts
- Headquarters
- Arlington, Massachusetts
- Most recent report
- 8-K, filed Aug 11, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1035354
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 72
News 8 of 252
Prospectuses and Registrations 8 of 60
- S-1 Registration statement for an offering Sep 11, 2026
- 424B4 Final prospectus for an offering Jun 9, 2026
- S-1/A Registration statement for an offering, amended Jun 4, 2026
- S-1/A Registration statement for an offering, amended Jun 1, 2026
- S-1 Registration statement for an offering May 7, 2026
- 25-NSE Notice that a security was delisted Mar 21, 2024
- S-3 Shelf registration statement Jan 25, 2024
- S-8 Registration statement for an employee plan Jan 24, 2024
Proxies 8 of 32
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Oct 31, 2022
- PRE 14A Preliminary proxy statement Oct 17, 2022
- DEFA14A Extra proxy material Apr 29, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2022
- DEFA14A Extra proxy material Apr 1, 2021
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2021
Ownership 8 of 521
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 3 Insider reported their initial holding Jun 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 16, 2026
Other 8 of 64
- EFFECT Notice that a registration became effective Sep 18, 2026
- EFFECT Notice that a registration became effective Jun 8, 2026
- CERT Exchange certified a listing Jun 8, 2026
- 8-A12B Registration of a security for exchange listing Jun 1, 2026
- DEF 14C May 8, 2026
- PRE 14C Apr 28, 2026
- DRS Draft registration statement, submitted confidentially Mar 20, 2026
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2025
Everything here comes from Eloxx Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.